Childhood absence epilepsy
Childhood absence epilepsy (CAE), also known as pyknolepsy, is an idiopathic generalized epilepsy which occurs in otherwise normal children. The age of onset is between 4–10 years with peak age between 5–7 years. Children have absence seizures which although brief (~4–20 seconds), they occur frequently, sometimes in the hundreds per day. The absence seizures of CAE involve abrupt and severe impairment of consciousness. Mild automatisms are frequent, but major motor involvement early in the course excludes this diagnosis. The EEG demonstrates characteristic "typical 3Hz spike-wave" discharges. Prognosis is excellent in well-defined cases of CAE with most patients "growing out" of their epilepsy.[1]
Causes
CAE is a complex polygenic disorder. Particularly in the Han Chinese population there is association between mutations in CACNA1H and CAE. These mutations cause increased channel activity and associated increased neuronal excitability. Seizures are believed to originate in the thalamus, where there is an abundance of T-type calcium channels such as those encoded by CACNA1H.
Pathophysiology
There are currently 20 mutations in CACNA1H associated with CAE. These mutations are likely not wholly causative and should instead be thought of as giving susceptibility. This is particularly true since some groups have found no connection between CAE and CACNA1H mutations.[2] Many of the CACNA1H mutations have a measurable effect on channel kinetics, including activation time constant and voltage dependence, deactivation time constant, and inactivation time constant and voltage dependence (summarized in Table 1). Many of these mutations should lead to neuronal excitability, though others may lead to hypoexcitability. These predictions are due to mathematical modeling and may differ from what will occur in real neurons where other proteins, some of which may interact with CACNA1H, are present.
Along with mutations in CACNA1H, two mutations in the gene encoding a GABAA receptor γ subunit are also associated with a CAE like phenotype that also overlaps with generalized epilepsy with febrile seizures plus type-3. The first of these, R43Q, abolishes benzodiazepine potentiation of GABA induced currents.[3][4] The second associated mutation, C588T has not been further characterized.
Mutation | Region | Activation | Deactivation | Inactivation | Excitability Prediction | References | ||
---|---|---|---|---|---|---|---|---|
V50 | Tau | V50 | Tau | |||||
F161L | D1S2-3 | Unchanged* | Unchanged | Depolarized | Accelerated | Unchanged | Hypoexcitable | [5],[6],[7] |
E282K | D1S5-6 | Hyperpolarized | Unchanged | Unchanged | Unchanged | Unchanged | Hypoexcitable | [5],[6],[7] |
P314S | D1-2 | ? | ? | ? | ? | ? | ? | [8] |
C456S | D1-2 | Hyperpolarized | Accelerated | Unchanged | Unchanged | Unchanged | Hyperexcitable | [5],[6],[7] |
A480T | D1-2 | ? | Unchanged | ? | ? | Unchanged | ? | [9],[10] |
P492S | D1-2 | ? | ? | ? | ? | ? | ? | [8],[8] |
G499S | D1-2 | Unchanged | Unchanged | Unchanged | Unchanged | Unchanged | Unchanged | [5],[7] |
P618L | D1-2 | ? | Accelerated | ? | ? | Accelerated | ? | [9],[10] |
V621fsX654 | D1-2 | ? | ? | ? | ? | ? | ? | [9] |
P648L | D1-2 | Unchanged | Unchanged | Unchanged | Depolarized | Slowed | Hyperexcitable | [5],[7] |
R744Q | D1-2 | Unchanged | Unchanged | Unchanged | Unchanged | Unchanged | Unchanged | [5],[7] |
A748V | D1-2 | Unchanged | Accelerated | Unchanged | Unchanged | Unchanged | Unchanged | [5],[7] |
G755D | D1-2 | ? | Unchanged | ? | ? | Accelerated | ? | [9],[10] |
G773D | D1-2 | Depolarized | Slowed | Slowed | Depolarized | Slowed | Hyperexcitable | [5],[7] |
G784S | D1-2 | Unchanged | Slowed | Unchanged | Unchanged | Unchanged | Unchanged | [5],[7] |
R788C | D1-2 | Depolarized | Slowed | Slowed | Unchanged | Slowed | Hyperexcitable | [7],[8] |
G773D + R788C | D1-2 | Unchanged | Unchanged | Slowed | Unchanged | Unchanged | Hyperexcitable | [7] |
V831M | D2S2 | Unchanged | Hyperpolarized | Slowed | Depolarized | Slowed | Hypoexcitable | [5],[6],[7] |
G848S | D2S2 | Unchanged | Unchanged | Slowed | Unchanged | Unchanged | Unchanged | [5],[7] |
D1463N | D2S5-6 | Unchanged | Accelerated | Unchanged | Unchanged | Unchanged | Unchanged | [5],[6],[7] |
* |
Depending on experimental paradigm |
Diagnosis
Diagnosis is made upon history of absence seizures during early childhood and the observation of ~3 Hz spike-and-wave discharges on an EEG.
Management
Epidemiology
Few of these people will likely have mutations in CACNA1H or GABRG2 as the prevalence of those in the studies presented is 10% or less.
References
- Perez-Reyes E (2006). "Molecular characterization of T-type calcium channels". Cell Calcium. 40 (2): 89–96. doi:10.1016/j.ceca.2006.04.012. PMID 16759699.
Footnotes
- Hirsch E, Thomas P, Panayiotopoulos C (2007). "Childhood and absence epilepsies". Epilepsy: A Comprehensive Textbook: 2397–2411.
- Chioza B, Everett K, Aschauer H, Brouwer O, Callenbach P, Covanis A, Dulac O, Durner M, Eeg-Olofsson O, Feucht M, Friis M, Heils A, Kjeldsen M, Larsson K, Lehesjoki A, Nabbout R, Olsson I, Sander T, Sirén A, Robinson R, Rees M, Gardiner R (2006). "Evaluation of CACNA1H in European patients with childhood absence epilepsy". Epilepsy Res. 69 (2): 177–81. doi:10.1016/j.eplepsyres.2006.01.009. PMID 16504478.
- Wallace R, Marini C, Petrou S, Harkin L, Bowser D, Panchal R, Williams D, Sutherland G, Mulley J, Scheffer I, Berkovic S (2001). "Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures". Nat Genet. 28 (1): 49–52. doi:10.1038/88259. PMID 11326275.
- Marini C, Harkin L, Wallace R, Mulley J, Scheffer I, Berkovic S (2003). "Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation". Brain. 126 (Pt 1): 230–40. doi:10.1093/brain/awg018. PMID 12477709.
- Chen Y, Lu J, Pan H, Zhang Y, Wu H, Xu K, Liu X, Jiang Y, Bao X, Yao Z, Ding K, Lo W, Qiang B, Chan P, Shen Y, Wu X (2003). "Association between genetic variation of CACNA1H and childhood absence epilepsy". Ann Neurol. 54 (2): 239–43. doi:10.1002/ana.10607. PMID 12891677.
- Khosravani H, Altier C, Simms B, Hamming K, Snutch T, Mezeyova J, McRory J, Zamponi G (2004). "Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy". J Biol Chem. 279 (11): 9681–4. doi:10.1074/jbc.C400006200. PMID 14729682.
- Vitko I, Chen Y, Arias J, Shen Y, Wu X, Perez-Reyes E (2005). "Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel". J Neurosci. 25 (19): 4844–55. doi:10.1523/JNEUROSCI.0847-05.2005. PMC 6724770. PMID 15888660.
- Liang J, Zhang Y, Wang J, Pan H, Wu H, Xu K, Liu X, Jiang Y, Shen Y, Wu X (2006). "New variants in the CACNA1H gene identified in childhood absence epilepsy". Neurosci Lett. 406 (1–2): 27–32. doi:10.1016/j.neulet.2006.06.073. PMID 16905256.
- Heron S, Phillips H, Mulley J, Mazarib A, Neufeld M, Berkovic S, Scheffer I (2004). "Genetic variation of CACNA1H in idiopathic generalized epilepsy". Ann Neurol. 55 (4): 595–6. doi:10.1002/ana.20028. PMID 15048902.
- Khosravani H, Bladen C, Parker D, Snutch T, McRory J, Zamponi G (2005). "Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy". Ann Neurol. 57 (5): 745–9. doi:10.1002/ana.20458. PMID 15852375.